Michael Millward

Professor, MB BS W.Aust., MA Melb., FRACP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 6585 Citations
  • 35 h-Index
20042021
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Cancer
  • Clinical trials

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 27 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Mutation Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Immunomagnetic-enriched subpopulations of melanoma circulating tumour cells (CTCs) exhibit distinct transcriptome profiles

Aya-Bonilla, C., Gray, E. S., Manikandan, J., Freeman, J. B., Zaenker, P., Reid, A. L., Khattak, M. A., Frank, M. H., Millward, M. & Ziman, M., 1 Feb 2019, In : Cancers. 11, 2, 157.

Research output: Contribution to journalArticle

Open Access
Circulating Neoplastic Cells
Transcriptome
Melanoma
Gene Expression
Epithelial-Mesenchymal Transition
1 Citation (Scopus)

Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma

Calapre, L., Giardina, T., Robinson, C., Reid, A. L., Al-Ogaili, Z., Pereira, M. R., McEvoy, A. C., Warburton, L., Hayward, N. K., Khattak, M. A., Meniawy, T. M., Millward, M., Amanuel, B., Ziman, M. & Gray, E. S., Feb 2019, In : Molecular Oncology. p. 171-184 14 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
DNA
Mutation
Neoplasms
Biopsy
1 Citation (Scopus)

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

Tio, M., Rai, R., Ezeoke, O. M., McQuade, J. L., Zimmer, L., Khoo, C., Park, J. J., Spain, L., Turajlic, S., Ardolino, L., Yip, D., Goldinger, S. M., Cohen, J. V., Millward, M., Atkinson, V., Kane, A. Y., Ascierto, P. A., Garbe, C., Gutzmer, R., Johnson, D. B. & 5 othersRizvi, H. A., Joshua, A. M., Hellmann, M. D., Long, G. V. & Menzies, A. M., Nov 2018, In : European Journal of Cancer. 104, p. 137-144 8 p.

Research output: Contribution to journalArticle

A Phase 1B Study of the Anti-PD-1 Monoclonal Antibody, Tislelizumab, in Combination with the Parp Inhibitor, Pamiparib, in Advanced Solid Tumors

Friedlander, M., Meniawy, T., Markman, B., Mileshkin, L. R., Harnett, P., Millward, M., Lundy, J., Freimund, A. E., Norris, C., Wu, J., Paton, V., Wang, L. & Gao, B., Aug 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 58-59 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Projects 2004 2021